The German Biotechnology Company Punitec/ Pfizer said today, Friday, that the new data from a clinical trial is currently showing a four -fold increase in neutralizing antibodies against the BA 5 and BA 4 strains in the age group over 55 years compared to whoever They received a reinforced dose of the original vaccine.
Both measurements were reportedly collected a month after the test subjects had received the activation dose.
After one month of this vaccine, a 9. 5-fold increase in the so-called antibodies in the component group between the ages of 18 and 55 was found as compared to the values that came before the reinforcement dose of vaccination. The age group over 55 years saw an increase that was 13.2 times larger.
The two corporations claimed that both vaccinations had two similarities in terms of both safety and efficacy.
The blood was tested from dozens of people in favor of the study.
It is significant that the European Union has since mid-September accepted the Bona 4 Bonteh/Pynezer upgrade. It has components that are active both against the new Omarron Museum captions and the Corona Virus Museum (BA 5 and BA 4)..
Punite: The modified Kofide vaccine outperforms the original vaccination in terms of effectiveness.
About Author
